Equity
€203,951 ▲ 51.1%
Equity rose in 2025 from €134,979 to €203,951.
SILYSTA
Lifetime
4 annual accounts with figures on one time axispeak €130,631 (2024)
€113,185▼ 13.4%
peak €70,384 (2024)
€68,972▼ 2.0%
peak €203,951 (2025)
€203,951▲ 51.1%
€29,663▼ 67.8%
Board1 name since 2022
1 director
Documentsfilings and deeds
17-03-2026136 days before the deadline
2025micro format
Gross margin from €130,631 to €113,185Equity from €134,979 to €203,951Debts from €92,132 to €29,663Cash from €17,680 to €7,579
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as SILYSTA has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for SILYSTA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0789889014
Incorporation
Founding capital of €2,500, 100 shares · Founder: · Appointment: (director) · published on 25-08-2022 · Gazette deed
First establishment
Nieuwenrodestraat 4, Meise
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SILYSTA Meise | €233,614 | €113,185 | 87.3% | - |
| MediVaes Linkebeek | €221,257 | €110,718 | 81.1% | - |
| DR. DAAN VANDENDOORENT Wemmel | €238,392 | €109,798 | 95.7% | - |
| JM Medical Consulting Grimbergen Grimbergen | €235,854 | €109,846 | 97.1% | - |
| Dr. Katherine Vandenborre Herent | €262,545 | €107,443 | 78.7% | 0 |
| DOCTEUR DOMONT PIERRE Braine-le-Château | €237,875 | €113,459 | 28.6% | - |
| NEUREVAL Wavre | €234,076 | €116,563 | 2.1% | - |
These companies have the same main activity as SILYSTA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €221,000 and €263,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 23-08-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220and 2 others
- Establishment unit
- 2.334.632.0281861 Meise, since 23-08-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 21-08-2025
Annual accounts 2025
- ≈ €210,000estimated
- €233,614▲ 2.9%
- Filing
- Filed on 17-03-2026, 136 days before the end of the filing period
Insights on SILYSTA
SILYSTA files the micro format. That format states no turnover. The gross margin rose from €12,504 in 2022 to €113,185 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SILYSTA
- What is the company number of SILYSTA?
- The company number of SILYSTA is 0789.889.014. The VAT number is the same number with BE in front: BE 0789.889.014.
- Where is SILYSTA based?
- The registered office is at Nieuwenrodestraat 4, 1861 Meise.Company details
- What does SILYSTA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of SILYSTA?
- SILYSTA is a private limited company (BV).
- When was SILYSTA founded?
- SILYSTA was founded on 23-08-2022.
- Is SILYSTA still active?
- Yes, SILYSTA is an active enterprise in the KBO register.
- What is the turnover of SILYSTA?
- The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €113,185 and 40 comparable companies (NACE 86220). It probably lies between €180,000 and €280,000.Financials
- Is SILYSTA profitable?
- In financial year 2025, SILYSTA made a profit of €68,972.
- Where can I find the annual accounts of SILYSTA?
- SILYSTA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SILYSTA due?
- SILYSTA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.